Advantage Alpha Capital Partners LP Dynavax Technologies Corp Transaction History
Advantage Alpha Capital Partners LP
- $387 Million
- Q4 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 25,098 shares of DVAX stock, worth $346,101. This represents 0.08% of its overall portfolio holdings.
Number of Shares
25,098
Previous 46,151
45.62%
Holding current value
$346,101
Previous $514,000
37.74%
% of portfolio
0.08%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$302 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$245 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$126 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$107 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$90.5 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.74B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...